David Liew

Panel discussion led by rheumatology experts Drs. Aurelie Najm, David Liew, and Jonathan Kay at EULAR 2024 meeting. Topics include disappointing trial results for bio-naive patients, challenges in treatment selection, importance of addressing depression, impact of medications on vaccination responses, debate on therapeutic drug monitoring in RA treatment, and use of innovative apps for remote patient monitoring in rheumatoid arthritis.

Dr. David Liew discusses the suboptimal responses of rheumatoid arthritis patients on abatacept to the Shingrix vaccine at Eular 2024. The chapter highlights the importance of improving vaccination strategies for this group to enhance vaccine response.